.gif)
Stay informed with Dubai Investments’ latest press releases, featuring key announcements, strategic initiatives, and industry insights. Explore our updates to stay connected with our growth, innovations, and contributions to the UAE’s dynamic economy.
February 16, 2026
Globalpharma, a wholly owned subsidiary of Dubai Investments and one of the UAE’s leading pharmaceutical manufacturers, has announced the signing of a strategic distribution agreement with United Medical Supplies (UNIMED) LLC, a key healthcare distributor under the Mohamed & Obaid Al Mulla Group. The agreement was formalized at the World Health Expo (WHX) 2026.
The collaboration marks an important step in expanding the reach of Globalpharma’s locally manufactured medicines across the UAE. By leveraging UNIMED’s extensive distribution network and capabilities, the partnership will enhance market access for Globalpharma’s expanding portfolio — including its 25 newly launched products — ensuring greater availability across pharmacies, hospitals, and key healthcare channels.
The agreement was signed at the UNIMED stand at the World Health Expo 2026 by Basem Al‑Barahmeh, General Manager of Globalpharma and Ahmad Jarrar, General Manager of UNIMED, reinforcing the shared commitment of both organizations to support the UAE’s vision for pharmaceutical self‑sufficiency and advanced local manufacturing.
Read More
Dubai Investments warns all investors to verify the identity of the entity they are dealing with before signing any agreements or making any financial transactions, and to refer to Data related to licensed companies published on the Dubai Financial Market’s website in order to avoid exposure to any fraudulent operations by unknown entities.
✓ Success
